Novavax Covid-19 vaccine approved for those aged 18 and above in Singapore

The vaccination regimen comprises two 5mcg doses of Nuvaxovid to be administered three weeks apart. - Reuters

SINGAPORE (The Straits Times/Asia News Network): The Covid-19 vaccine developed by Novavax has been approved for individuals here aged 18 and above, said the Health Sciences Authority (HSA) on Monday (Feb 14).

HSA had granted interim authorisation for Novavax's vaccine - manufactured under the name Nuvaxovid - on Feb 3 under the Pandemic Special Access Route (PSAR).